452 results on '"van Gilst, W. H."'
Search Results
2. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
3. Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study
4. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
5. Pathofysiologische en moleculaire aspecten van hartfalen
6. Local Effects of Angiotensin-Converting Enzyme Inhibitors on the Vascular Wall
7. Neurohumoral Regulation in Silent Myocardial Ischemia
8. Endothelial Function
9. The Role of Vascular Failure in Heart Failure
10. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial
11. Einthoven dissertation prizes 2012
12. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
13. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
14. Einthoven dissertation prizes 2011
15. Einthoven dissertation prize 2010
16. Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium
17. The PREVEND risk model for new onset heart failure with preserved and reduced ejection fraction: 681
18. Cholesteryl Ester Transfer Protein Polymorphisms, Statin Use, and Their Impact on Cholesterol Levels and Cardiovascular Events
19. Telomere length loss due to smoking and metabolic traits
20. Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles
21. Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 2: Pharmacological targets, agents and intervention perspectives
22. Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources
23. Rescue of arterial function by angiotensin-(1-7): towards improvement of endothelial function by drug-eluting stents
24. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
25. N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort
26. Cardiac overexpression of human VEGF165 by recombinant Semliki Forest virus leads to adverse effects in pressure-induced heart failure
27. Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study
28. Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta
29. The fibrosis marker galectin-3 and outcome in the general population
30. 8 Grondbeginselen van de farmacologie en het klinisch- (farmaco)therapeutisch onderzoek
31. Einthoven Dissertation Prize 2010
32. Sex-related differences in inflammation-associated biomarkers and their predictive utility for new-onset heart failure
33. Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds
34. Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits
35. Prescribing for chronic heart failure in Europe: does the country make the difference? A European survey†
36. Abstracts of papers and posters
37. Abstracts of papers and posters Clinical Pharmacological Meeting
38. Abstracts of papers clinical pharmacological meeting
39. Prescribing for chronic heart failure in Europe: does the country make a difference?
40. IMPAIRED EDHF-DILATION CORRELATED WITH INCREASED MYOGENIC CONSTRICTION IN MESENTERIC RESISTANCE ARTERIES DURING PROGRESSION OF HEART FAILURE: S2O16
41. New Pharmacological Strategies in Chronic Heart Failure
42. The Role of Vascular Failure in Heart Failure
43. Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism
44. Beneficial effects of bradykinin on porcine ischemic myocardium
45. DD ACE gene polymorphism is associated with increased coronary artery endothelial dysfunction: the PREFACE trial
46. Identification of a specific pattern of downregulation in expression of isoforms of vascular endothelial growth factor in dilated cardiomyopathy
47. Safety Evaluation of Routine Intracoronary Acetylcholine Infusion in Patients Undergoing a First Diagnostic Coronary Angiogram
48. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity
49. Increased risk for ischaemic events is related to combined RAS polymorphism
50. Do inflammation-associated biomarkers differ between men and women in prediction of new-onset heart failure ?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.